Mesalamine 1.2g Extended-Release Tablets from Canada
Anti-inflammatory tablets for ulcerative colitis maintenance therapy. Falls under HTS 3004.90.92.60 for therapeutic digestive products in measured doses.
Duty Rate — Canada → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Submit ANDA equivalence data for generics
• Ensure moisture-proof packaging for stability
• Differentiate from immunological biologics in 3002